Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 12/01/26
Due: 12/01/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Deprescribing and Health-related Effects | NCT05721534 | Anne Estrup Olesen | user2@example.com | None | 2020-01-01 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes | NCT04990986 | Anne Estrup Olesen | user2@example.com | None | 2020-10-01 | 2023-10-31 | 2024-10-31 | - | - | 2025-07-14 |
| Deprescribing DRrugs for Overactive Bladder in General Practice (DROP) | NCT06110975 | Anne Estrup Olesen | user2@example.com | None | 2023-12-01 | 2026-12-01 | 2027-12-01 | - | - | 2025-07-14 |